Currently out of the existing stock ratings of David Grossman, 157 are a BUY (68.26%), 73 are a HOLD (31.74%).

David Grossman

Work Performance Price Targets & Ratings Chart

Analyst David Grossman, currently employed at STIFEL, carries an average stock price target met ratio of 70.62% that have a potential upside of 18.04% achieved within 179 days.

David Grossman’s has documented 420 price targets and ratings displayed on 23 stocks. The coverage is on Healthcare, Technology, Industrials sectors.

Most recent stock forecast was given on PAYX, Paychex at 02-Oct-2024.

Wall Street Analyst David Grossman

Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for DXC (DXC TECHNOLOGY CO) at 3/11/2020. The price target of $15 was fulfilled within 1 day with a profit of $1.11 (6.89%) receiving and performance score of 68.9.

Average potential price target upside

of $48.44 (23.8%) on EPAM (EPAM SYSTEMS).
of $46.02 (44.51%) on IBM (INTERNATIONAL BUSINESS MACHINES).
of $38.33 (20.99%) on ACN (ACCENTURE PLC).

ACCD Accolade ACN Accenture plc ADP Automatic Data Processing CERN Cerner Corp DCGO DocGo DXC DXC Technology Co ENV Envestnet EPAM EPAM Systems EXLS ExlService Holdings IBM International Business Machines LVGO Livongo Health PAYX Paychex TDOC Teladoc TNET TriNet Group TRHC Tabula Rasa HealthCare AMWL American Well Corp ATHN athenahealth DRIO DarioHealth Corp HCAT Health Catalyst INFY Infosys Ltd ADR OPRX OPTIMIZERx Corp VEEV Veeva Systems DH Definitive Healthcare Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ricky Goldwasser (MORGAN STANLEY)